David A. Jenkins - 09 Jan 2023 Form 4 Insider Report for Ra Medical Systems, Inc. (VTAK)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Shares After	Date	Underlying Class	Amount	Ownership	Footnotes
transaction	RMED	Series X Convertible Preferred Stock	Award	+2,570	2,570	09 Jan 2023	Common Stock	2,569,936	Direct	F1, F2, F3
transaction	RMED	Series X Convertible Preferred Stock	Award	+21	21	09 Jan 2023	Common Stock	20,955	See footnote	F1, F2, F3, F4
transaction	RMED	Series X Convertible Preferred Stock	Award	+6,570	6,570	09 Jan 2023	Common Stock	6,570,243	See footnote	F1, F2, F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.
F2	On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000).
F3	Series X Convertible Preferred Stock has no expiration date
F4	Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.
F5	Shares held by a partnership of which the reporting person is the managing member of the managing partner.